Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bipolar Disorder | 82 | 2018 | 5027 | 5.240 |
Why?
|
United States Department of Veterans Affairs | 28 | 2020 | 875 | 4.300 |
Why?
|
Mental Health Services | 26 | 2020 | 1644 | 3.730 |
Why?
|
Patient Care Team | 13 | 2020 | 2531 | 2.830 |
Why?
|
Cooperative Behavior | 22 | 2020 | 1504 | 2.790 |
Why?
|
Veterans | 32 | 2020 | 2519 | 2.520 |
Why?
|
Mental Disorders | 26 | 2020 | 6598 | 2.420 |
Why?
|
Antipsychotic Agents | 19 | 2018 | 3057 | 2.110 |
Why?
|
Antimanic Agents | 8 | 2016 | 522 | 1.300 |
Why?
|
Models, Organizational | 7 | 2020 | 574 | 1.210 |
Why?
|
Health Plan Implementation | 5 | 2019 | 352 | 1.210 |
Why?
|
Self Care | 14 | 2016 | 786 | 1.200 |
Why?
|
Long-Term Care | 5 | 2019 | 607 | 1.080 |
Why?
|
Primary Health Care | 11 | 2019 | 4557 | 1.040 |
Why?
|
Mood Disorders | 7 | 2019 | 1106 | 1.010 |
Why?
|
Interprofessional Relations | 3 | 2018 | 1011 | 0.970 |
Why?
|
Community Mental Health Services | 9 | 2019 | 386 | 0.950 |
Why?
|
Hospitals, Veterans | 6 | 2019 | 404 | 0.870 |
Why?
|
Organizational Innovation | 4 | 2020 | 559 | 0.830 |
Why?
|
Delivery of Health Care, Integrated | 5 | 2013 | 941 | 0.820 |
Why?
|
Patient-Centered Care | 5 | 2019 | 1438 | 0.760 |
Why?
|
Off-Label Use | 3 | 2017 | 169 | 0.760 |
Why?
|
Evidence-Based Practice | 4 | 2019 | 501 | 0.740 |
Why?
|
Stress Disorders, Post-Traumatic | 9 | 2017 | 4266 | 0.740 |
Why?
|
Disease Management | 5 | 2019 | 2460 | 0.720 |
Why?
|
Quality of Life | 19 | 2019 | 12802 | 0.710 |
Why?
|
United States | 54 | 2020 | 69872 | 0.700 |
Why?
|
Quality of Health Care | 10 | 2019 | 4369 | 0.650 |
Why?
|
Diffusion of Innovation | 3 | 2015 | 725 | 0.650 |
Why?
|
Self Report | 3 | 2019 | 3553 | 0.640 |
Why?
|
Mentally Ill Persons | 1 | 2018 | 126 | 0.620 |
Why?
|
Evidence-Based Medicine | 7 | 2019 | 3611 | 0.620 |
Why?
|
Telemedicine | 5 | 2020 | 2872 | 0.580 |
Why?
|
Telecommunications | 1 | 2017 | 80 | 0.580 |
Why?
|
Psychiatric Status Rating Scales | 17 | 2019 | 6036 | 0.570 |
Why?
|
Comparative Effectiveness Research | 4 | 2016 | 680 | 0.570 |
Why?
|
Health Status | 8 | 2017 | 4034 | 0.560 |
Why?
|
Suicide | 6 | 2014 | 1474 | 0.550 |
Why?
|
Love | 1 | 2016 | 37 | 0.540 |
Why?
|
Psychiatry | 7 | 2019 | 1695 | 0.540 |
Why?
|
Medication Therapy Management | 1 | 2016 | 127 | 0.530 |
Why?
|
Health Services Research | 9 | 2020 | 1836 | 0.520 |
Why?
|
Psychometrics | 6 | 2019 | 3003 | 0.520 |
Why?
|
Program Development | 6 | 2019 | 1316 | 0.520 |
Why?
|
Chronic Disease | 10 | 2019 | 9145 | 0.510 |
Why?
|
Middle Aged | 80 | 2020 | 213390 | 0.510 |
Why?
|
Videoconferencing | 2 | 2020 | 195 | 0.500 |
Why?
|
Multicenter Studies as Topic | 2 | 2019 | 1677 | 0.500 |
Why?
|
Adult | 78 | 2020 | 214052 | 0.490 |
Why?
|
Personal Satisfaction | 2 | 2018 | 643 | 0.480 |
Why?
|
Self-Injurious Behavior | 1 | 2019 | 464 | 0.480 |
Why?
|
Male | 97 | 2020 | 350115 | 0.470 |
Why?
|
Cardiovascular Diseases | 11 | 2017 | 15160 | 0.470 |
Why?
|
Employment | 3 | 2013 | 1132 | 0.460 |
Why?
|
Behavioral Research | 1 | 2013 | 54 | 0.460 |
Why?
|
Physicians, Primary Care | 2 | 2017 | 592 | 0.460 |
Why?
|
Behavior Control | 1 | 2013 | 45 | 0.450 |
Why?
|
Computers | 1 | 2016 | 612 | 0.450 |
Why?
|
Humans | 133 | 2020 | 744366 | 0.440 |
Why?
|
Single-Blind Method | 5 | 2019 | 1590 | 0.440 |
Why?
|
Female | 96 | 2020 | 380193 | 0.440 |
Why?
|
Science | 1 | 2015 | 241 | 0.430 |
Why?
|
Health Services Accessibility | 13 | 2016 | 5135 | 0.430 |
Why?
|
Schizophrenia | 9 | 2017 | 6882 | 0.430 |
Why?
|
Attitude to Health | 5 | 2009 | 2052 | 0.410 |
Why?
|
Ambulatory Care Facilities | 4 | 2020 | 934 | 0.410 |
Why?
|
Comorbidity | 19 | 2018 | 10388 | 0.410 |
Why?
|
Cardiac Care Facilities | 1 | 2011 | 35 | 0.410 |
Why?
|
Interdisciplinary Communication | 2 | 2017 | 950 | 0.390 |
Why?
|
Goals | 2 | 2014 | 707 | 0.390 |
Why?
|
Epidemiologic Research Design | 1 | 2014 | 367 | 0.380 |
Why?
|
Valproic Acid | 3 | 2016 | 445 | 0.380 |
Why?
|
Qualitative Research | 6 | 2020 | 2682 | 0.370 |
Why?
|
Polypharmacy | 1 | 2013 | 294 | 0.370 |
Why?
|
Depression | 14 | 2019 | 7759 | 0.370 |
Why?
|
Clozapine | 2 | 2013 | 498 | 0.370 |
Why?
|
Suicide, Attempted | 6 | 2008 | 1218 | 0.360 |
Why?
|
Knowledge Bases | 1 | 2010 | 85 | 0.360 |
Why?
|
Patient Care Planning | 4 | 2015 | 921 | 0.350 |
Why?
|
Professional-Patient Relations | 5 | 2009 | 737 | 0.350 |
Why?
|
Quality Improvement | 7 | 2019 | 3749 | 0.350 |
Why?
|
Quinolones | 1 | 2012 | 367 | 0.340 |
Why?
|
Psychotic Disorders | 5 | 2013 | 3046 | 0.330 |
Why?
|
Patient Preference | 1 | 2016 | 889 | 0.330 |
Why?
|
Guideline Adherence | 4 | 2010 | 2265 | 0.320 |
Why?
|
Patient Compliance | 6 | 2009 | 2684 | 0.300 |
Why?
|
Research Design | 4 | 2019 | 5984 | 0.300 |
Why?
|
Patient Care Management | 3 | 2016 | 306 | 0.290 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2019 | 9955 | 0.290 |
Why?
|
Drug Therapy, Combination | 3 | 2016 | 6489 | 0.290 |
Why?
|
Behavior Therapy | 2 | 2012 | 865 | 0.290 |
Why?
|
Residence Characteristics | 1 | 2016 | 2050 | 0.290 |
Why?
|
Biomedical Research | 2 | 2019 | 3309 | 0.280 |
Why?
|
Peer Review, Research | 2 | 2006 | 329 | 0.270 |
Why?
|
Practice Guidelines as Topic | 6 | 2014 | 7282 | 0.260 |
Why?
|
Quality Indicators, Health Care | 3 | 2016 | 1831 | 0.260 |
Why?
|
Patient Education as Topic | 7 | 2018 | 2278 | 0.260 |
Why?
|
Paroxetine | 1 | 2006 | 182 | 0.250 |
Why?
|
Patient Selection | 2 | 2014 | 4216 | 0.250 |
Why?
|
Clinical Trials as Topic | 2 | 2019 | 7914 | 0.250 |
Why?
|
Cost of Illness | 3 | 2017 | 1860 | 0.250 |
Why?
|
Physician-Patient Relations | 2 | 2016 | 3229 | 0.250 |
Why?
|
Aged | 24 | 2020 | 163288 | 0.240 |
Why?
|
Review Literature as Topic | 1 | 2006 | 336 | 0.240 |
Why?
|
Program Evaluation | 5 | 2019 | 2488 | 0.240 |
Why?
|
Therapy, Computer-Assisted | 2 | 2019 | 271 | 0.240 |
Why?
|
Geriatrics | 1 | 2008 | 397 | 0.230 |
Why?
|
Substance-Related Disorders | 5 | 2009 | 4257 | 0.230 |
Why?
|
Clinical Competence | 2 | 2016 | 4687 | 0.220 |
Why?
|
Liver Failure, Acute | 1 | 2005 | 165 | 0.220 |
Why?
|
Exercise | 2 | 2017 | 5615 | 0.220 |
Why?
|
Health Care Reform | 1 | 2012 | 1261 | 0.220 |
Why?
|
Overweight | 1 | 2014 | 2371 | 0.220 |
Why?
|
Delivery of Health Care | 3 | 2016 | 5321 | 0.220 |
Why?
|
Anxiety Disorders | 4 | 2016 | 2690 | 0.220 |
Why?
|
Disease | 1 | 2008 | 680 | 0.220 |
Why?
|
Cross-Sectional Studies | 20 | 2017 | 25039 | 0.220 |
Why?
|
Dementia | 1 | 2017 | 2518 | 0.220 |
Why?
|
Antidepressive Agents | 4 | 2016 | 2838 | 0.220 |
Why?
|
Mental Health | 4 | 2019 | 3010 | 0.220 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2006 | 503 | 0.210 |
Why?
|
Piperazines | 1 | 2012 | 2488 | 0.210 |
Why?
|
Factor Analysis, Statistical | 2 | 2018 | 977 | 0.200 |
Why?
|
Faculty, Medical | 1 | 2010 | 1181 | 0.200 |
Why?
|
Conflict of Interest | 1 | 2006 | 544 | 0.200 |
Why?
|
Logistic Models | 9 | 2019 | 13409 | 0.200 |
Why?
|
Lithium Carbonate | 3 | 2008 | 184 | 0.200 |
Why?
|
Self-Assessment | 1 | 2003 | 390 | 0.200 |
Why?
|
Insurance Claim Review | 2 | 2019 | 720 | 0.200 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 7 | 2010 | 1953 | 0.180 |
Why?
|
Patient Satisfaction | 7 | 2017 | 3395 | 0.180 |
Why?
|
Psychotherapy | 4 | 2018 | 1642 | 0.180 |
Why?
|
Continuity of Patient Care | 5 | 2009 | 1049 | 0.180 |
Why?
|
Case Management | 3 | 2006 | 286 | 0.170 |
Why?
|
Ambulatory Care | 4 | 2019 | 2708 | 0.170 |
Why?
|
Alcoholism | 4 | 2005 | 1906 | 0.170 |
Why?
|
Anticonvulsants | 3 | 2006 | 1916 | 0.160 |
Why?
|
Interinstitutional Relations | 2 | 2012 | 241 | 0.160 |
Why?
|
United States Substance Abuse and Mental Health Services Administration | 1 | 2018 | 20 | 0.160 |
Why?
|
Severity of Illness Index | 11 | 2014 | 15535 | 0.160 |
Why?
|
Treatment Outcome | 17 | 2018 | 63107 | 0.160 |
Why?
|
Comprehensive Health Care | 1 | 2019 | 127 | 0.160 |
Why?
|
Community Health Services | 2 | 2016 | 650 | 0.160 |
Why?
|
Empirical Research | 1 | 2018 | 120 | 0.150 |
Why?
|
Longitudinal Studies | 9 | 2018 | 13991 | 0.150 |
Why?
|
Prospective Studies | 16 | 2018 | 53290 | 0.150 |
Why?
|
Academic Medical Centers | 1 | 2008 | 2760 | 0.150 |
Why?
|
Space-Time Clustering | 1 | 2016 | 49 | 0.150 |
Why?
|
Alcohol-Related Disorders | 2 | 2009 | 234 | 0.150 |
Why?
|
Michigan | 2 | 2019 | 350 | 0.140 |
Why?
|
Statistics as Topic | 3 | 2017 | 2373 | 0.140 |
Why?
|
Coronary Disease | 1 | 2011 | 6077 | 0.140 |
Why?
|
Triiodothyronine | 1 | 2018 | 494 | 0.140 |
Why?
|
Follow-Up Studies | 14 | 2018 | 39052 | 0.140 |
Why?
|
Models, Theoretical | 1 | 2008 | 3589 | 0.140 |
Why?
|
Minority Groups | 4 | 2009 | 1221 | 0.140 |
Why?
|
Depressive Disorder | 4 | 2017 | 3747 | 0.140 |
Why?
|
Costs and Cost Analysis | 2 | 2020 | 1680 | 0.140 |
Why?
|
Professional Role | 1 | 2019 | 306 | 0.140 |
Why?
|
Risk Reduction Behavior | 2 | 2013 | 1125 | 0.130 |
Why?
|
Socioeconomic Factors | 3 | 2017 | 7785 | 0.130 |
Why?
|
Periodicals as Topic | 1 | 2006 | 1431 | 0.130 |
Why?
|
Attitude of Health Personnel | 4 | 2019 | 3841 | 0.130 |
Why?
|
Community Mental Health Centers | 2 | 2012 | 102 | 0.130 |
Why?
|
Affect | 2 | 2018 | 1475 | 0.130 |
Why?
|
Waiting Lists | 1 | 2019 | 692 | 0.120 |
Why?
|
Inappropriate Prescribing | 1 | 2017 | 202 | 0.120 |
Why?
|
Combined Modality Therapy | 4 | 2013 | 8642 | 0.120 |
Why?
|
Thyroxine | 1 | 2018 | 667 | 0.120 |
Why?
|
Internet | 3 | 2019 | 3056 | 0.120 |
Why?
|
Medication Adherence | 3 | 2018 | 2063 | 0.120 |
Why?
|
Administrative Personnel | 1 | 2015 | 187 | 0.120 |
Why?
|
Health Care Costs | 4 | 2020 | 3208 | 0.120 |
Why?
|
Pilot Projects | 4 | 2012 | 8319 | 0.120 |
Why?
|
Risk Factors | 8 | 2019 | 72296 | 0.110 |
Why?
|
Internship and Residency | 2 | 2011 | 5791 | 0.110 |
Why?
|
Lithium | 1 | 2016 | 601 | 0.110 |
Why?
|
Diabetes Mellitus | 3 | 2018 | 5749 | 0.110 |
Why?
|
Health Status Disparities | 2 | 2019 | 1796 | 0.110 |
Why?
|
Data Collection | 3 | 2012 | 3339 | 0.110 |
Why?
|
Reminder Systems | 1 | 2016 | 371 | 0.110 |
Why?
|
Reproducibility of Results | 6 | 2018 | 19905 | 0.110 |
Why?
|
Trust | 1 | 2017 | 505 | 0.110 |
Why?
|
Self-Help Groups | 1 | 2014 | 190 | 0.110 |
Why?
|
Hospitalization | 4 | 2020 | 10259 | 0.100 |
Why?
|
Disability Evaluation | 3 | 2009 | 1828 | 0.100 |
Why?
|
Cohort Studies | 8 | 2016 | 40559 | 0.100 |
Why?
|
Social Support | 2 | 2013 | 2118 | 0.100 |
Why?
|
Time Factors | 9 | 2019 | 40075 | 0.100 |
Why?
|
Medical Audit | 1 | 2012 | 467 | 0.100 |
Why?
|
Demography | 5 | 2011 | 1655 | 0.100 |
Why?
|
Public-Private Sector Partnerships | 1 | 2012 | 121 | 0.100 |
Why?
|
Body Mass Index | 3 | 2014 | 12721 | 0.100 |
Why?
|
Interview, Psychological | 3 | 2009 | 812 | 0.090 |
Why?
|
Perception | 1 | 2017 | 1198 | 0.090 |
Why?
|
Mid-Atlantic Region | 1 | 2009 | 23 | 0.090 |
Why?
|
International Classification of Diseases | 2 | 2013 | 867 | 0.090 |
Why?
|
Competency-Based Education | 1 | 2011 | 211 | 0.090 |
Why?
|
Job Satisfaction | 1 | 2013 | 534 | 0.090 |
Why?
|
Veterans Health | 1 | 2011 | 216 | 0.090 |
Why?
|
Interviews as Topic | 2 | 2007 | 2539 | 0.080 |
Why?
|
Nursing Care | 1 | 2009 | 74 | 0.080 |
Why?
|
Cyclothymic Disorder | 2 | 2008 | 41 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1956 | 0.080 |
Why?
|
Outpatients | 1 | 2016 | 1487 | 0.080 |
Why?
|
Specialty Boards | 1 | 2010 | 227 | 0.080 |
Why?
|
Home Nursing | 1 | 2008 | 92 | 0.080 |
Why?
|
Models, Educational | 1 | 2011 | 377 | 0.080 |
Why?
|
Likelihood Functions | 2 | 2008 | 1005 | 0.080 |
Why?
|
Regression Analysis | 3 | 2013 | 6459 | 0.080 |
Why?
|
Community-Based Participatory Research | 1 | 2009 | 214 | 0.080 |
Why?
|
Leadership | 1 | 2017 | 1357 | 0.080 |
Why?
|
Health Surveys | 4 | 2012 | 4036 | 0.080 |
Why?
|
Accreditation | 1 | 2010 | 452 | 0.070 |
Why?
|
Psychotherapy, Group | 2 | 2008 | 406 | 0.070 |
Why?
|
Blood Pressure | 2 | 2014 | 8551 | 0.070 |
Why?
|
Nurses | 1 | 2016 | 2462 | 0.070 |
Why?
|
Risperidone | 2 | 2006 | 383 | 0.070 |
Why?
|
Registries | 4 | 2012 | 8091 | 0.070 |
Why?
|
Medical History Taking | 1 | 2010 | 784 | 0.070 |
Why?
|
Cost-Benefit Analysis | 4 | 2006 | 5388 | 0.070 |
Why?
|
Documentation | 2 | 2010 | 871 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2017 | 77460 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2017 | 57776 | 0.070 |
Why?
|
Personality Inventory | 1 | 2009 | 1030 | 0.070 |
Why?
|
Carbamazepine | 1 | 2007 | 229 | 0.070 |
Why?
|
Clinical Protocols | 1 | 2012 | 1461 | 0.070 |
Why?
|
Information Services | 1 | 2007 | 244 | 0.070 |
Why?
|
Pensions | 1 | 2005 | 15 | 0.070 |
Why?
|
Peer Group | 1 | 2010 | 635 | 0.060 |
Why?
|
Inositol | 1 | 2006 | 218 | 0.060 |
Why?
|
Nurse Clinicians | 1 | 2004 | 31 | 0.060 |
Why?
|
Treatment Refusal | 1 | 2008 | 421 | 0.060 |
Why?
|
United States Food and Drug Administration | 1 | 2012 | 1584 | 0.060 |
Why?
|
Self Disclosure | 1 | 2006 | 251 | 0.060 |
Why?
|
Attitude | 1 | 2009 | 776 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2951 | 0.060 |
Why?
|
Hospitals, Psychiatric | 1 | 2005 | 332 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2019 | 21748 | 0.060 |
Why?
|
Depressive Disorder, Major | 5 | 2009 | 4639 | 0.060 |
Why?
|
Triazines | 1 | 2006 | 315 | 0.060 |
Why?
|
Medicine | 1 | 2012 | 946 | 0.060 |
Why?
|
Age Distribution | 1 | 2010 | 2902 | 0.060 |
Why?
|
Authorship | 1 | 2006 | 271 | 0.060 |
Why?
|
Drug Prescriptions | 1 | 2013 | 1637 | 0.060 |
Why?
|
Prevalence | 4 | 2014 | 15221 | 0.060 |
Why?
|
Public Sector | 1 | 2005 | 265 | 0.060 |
Why?
|
Antithyroid Agents | 1 | 2003 | 70 | 0.060 |
Why?
|
Teaching | 1 | 2011 | 1174 | 0.060 |
Why?
|
Combat Disorders | 1 | 2005 | 302 | 0.060 |
Why?
|
Personality Assessment | 1 | 2005 | 647 | 0.050 |
Why?
|
Communication | 1 | 2017 | 3750 | 0.050 |
Why?
|
Child Abuse, Sexual | 1 | 2005 | 383 | 0.050 |
Why?
|
Probability | 1 | 2008 | 2506 | 0.050 |
Why?
|
Complementary Therapies | 1 | 2007 | 486 | 0.050 |
Why?
|
Research Support as Topic | 1 | 2006 | 705 | 0.050 |
Why?
|
Young Adult | 2 | 2019 | 56429 | 0.050 |
Why?
|
Military Personnel | 1 | 2011 | 1133 | 0.050 |
Why?
|
Neurology | 1 | 2010 | 763 | 0.050 |
Why?
|
Guidelines as Topic | 1 | 2008 | 1405 | 0.050 |
Why?
|
Activities of Daily Living | 2 | 2009 | 2419 | 0.050 |
Why?
|
Health Services Needs and Demand | 1 | 2009 | 1410 | 0.050 |
Why?
|
Hypertension | 2 | 2012 | 8479 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2010 | 12244 | 0.050 |
Why?
|
California | 1 | 2005 | 1402 | 0.050 |
Why?
|
Reaction Time | 1 | 2007 | 2098 | 0.050 |
Why?
|
Drug Monitoring | 1 | 2007 | 956 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2017 | 4468 | 0.050 |
Why?
|
Managed Care Programs | 1 | 2006 | 950 | 0.050 |
Why?
|
Office Visits | 1 | 2005 | 598 | 0.050 |
Why?
|
Curriculum | 2 | 2011 | 3605 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2010 | 5077 | 0.050 |
Why?
|
Lipids | 1 | 2011 | 3307 | 0.050 |
Why?
|
Patient Participation | 1 | 2009 | 1457 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2005 | 1851 | 0.040 |
Why?
|
Linear Models | 1 | 2010 | 5953 | 0.040 |
Why?
|
Colorado | 1 | 2019 | 163 | 0.040 |
Why?
|
Vulnerable Populations | 1 | 2005 | 686 | 0.040 |
Why?
|
Drug Costs | 1 | 2006 | 1105 | 0.040 |
Why?
|
Schizophrenic Psychology | 1 | 2006 | 1678 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 426 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2005 | 1547 | 0.040 |
Why?
|
Pennsylvania | 2 | 2009 | 613 | 0.040 |
Why?
|
Thyroid Function Tests | 1 | 2018 | 286 | 0.040 |
Why?
|
Odds Ratio | 1 | 2010 | 9849 | 0.040 |
Why?
|
Mortality | 1 | 2008 | 2864 | 0.040 |
Why?
|
Blood Glucose | 1 | 2011 | 6254 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7658 | 0.040 |
Why?
|
Child Abuse | 1 | 2005 | 1030 | 0.040 |
Why?
|
Thyroid Gland | 1 | 2003 | 1173 | 0.030 |
Why?
|
Informed Consent | 1 | 2002 | 995 | 0.030 |
Why?
|
ROC Curve | 1 | 2003 | 3528 | 0.030 |
Why?
|
Thyroid Hormones | 1 | 2018 | 390 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2004 | 1856 | 0.030 |
Why?
|
Adolescent | 8 | 2009 | 85779 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4567 | 0.030 |
Why?
|
Age Factors | 2 | 2009 | 18373 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2007 | 6994 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2010 | 3154 | 0.030 |
Why?
|
Pain Measurement | 1 | 2003 | 3420 | 0.030 |
Why?
|
Risk | 1 | 2006 | 9688 | 0.030 |
Why?
|
Acute Disease | 1 | 2004 | 7147 | 0.030 |
Why?
|
Health Personnel | 2 | 2006 | 3219 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2008 | 12961 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2019 | 2715 | 0.030 |
Why?
|
Patient Readmission | 1 | 2006 | 3116 | 0.030 |
Why?
|
Panic Disorder | 2 | 2005 | 616 | 0.020 |
Why?
|
Self Efficacy | 1 | 2012 | 615 | 0.020 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2009 | 295 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 14723 | 0.020 |
Why?
|
Risk Assessment | 2 | 2008 | 23336 | 0.020 |
Why?
|
Recreation | 1 | 2008 | 115 | 0.020 |
Why?
|
Diabetic Foot | 1 | 2011 | 355 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2003 | 15078 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2002 | 3922 | 0.020 |
Why?
|
Arthritis | 1 | 2012 | 661 | 0.020 |
Why?
|
Research Personnel | 1 | 2012 | 573 | 0.020 |
Why?
|
Epidemiology | 1 | 2009 | 287 | 0.020 |
Why?
|
Insurance, Psychiatric | 1 | 2006 | 69 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2012 | 1530 | 0.020 |
Why?
|
Washington | 1 | 2006 | 313 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2007 | 528 | 0.020 |
Why?
|
Population Surveillance | 2 | 2007 | 2616 | 0.020 |
Why?
|
Social Adjustment | 1 | 2007 | 631 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2005 | 321 | 0.020 |
Why?
|
Focus Groups | 1 | 2009 | 1321 | 0.020 |
Why?
|
Agoraphobia | 1 | 2004 | 179 | 0.020 |
Why?
|
Resource Allocation | 1 | 2006 | 341 | 0.020 |
Why?
|
Family Practice | 1 | 2007 | 516 | 0.020 |
Why?
|
Patient Dropouts | 1 | 2006 | 420 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12025 | 0.010 |
Why?
|
Personality | 1 | 2008 | 552 | 0.010 |
Why?
|
Vitamin B Complex | 1 | 2006 | 288 | 0.010 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 2003 | 147 | 0.010 |
Why?
|
Sex Factors | 2 | 2008 | 10400 | 0.010 |
Why?
|
Psychology | 1 | 2005 | 356 | 0.010 |
Why?
|
Health Behavior | 1 | 2014 | 2635 | 0.010 |
Why?
|
Research | 1 | 2011 | 1999 | 0.010 |
Why?
|
Anti-Anxiety Agents | 1 | 2004 | 390 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2012 | 2575 | 0.010 |
Why?
|
Indians, North American | 1 | 2005 | 355 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2006 | 1101 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.010 |
Why?
|
Age of Onset | 1 | 2007 | 3270 | 0.010 |
Why?
|
Aftercare | 1 | 2006 | 870 | 0.010 |
Why?
|
Thyrotropin | 1 | 2003 | 849 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 4933 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2011 | 3086 | 0.010 |
Why?
|
Recovery of Function | 1 | 2006 | 2926 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2004 | 2212 | 0.010 |
Why?
|
Recurrence | 1 | 2006 | 8340 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2004 | 3658 | 0.010 |
Why?
|
Algorithms | 1 | 2004 | 13882 | 0.000 |
Why?
|
Child | 1 | 2005 | 77709 | 0.000 |
Why?
|